Washington Trust Bank Gsk PLC Transaction History

Washington Trust Bank

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 26, 2019	SELL	$39.4 - $42.7 $26,595 - $28,822	-675 Closed	0 $0
Q1 2019 Apr 09, 2019	BUY	$38.57 - $42.69 $2,352 - $2,604	61 Added 9.93%	675 $29,000
Q4 2018 Feb 13, 2019	SELL	$37.8 - $42.69 $226 - $256	-6 Reduced 0.97%	614 $24,000
Q3 2018 Nov 14, 2018	BUY	$39.75 - $42.69 $2,424 - $2,604	61 Added 10.91%	620 $24,000
Q1 2018 Apr 03, 2018	SELL	$36.18 - $40.15 $2,713 - $3,011	-75 Reduced 11.83%	559 $22,000
Q4 2017 Jan 03, 2018	SELL	$35.34 - $41.9 $103,369 - $122,557	-2,925 Reduced 82.19%	634 $23,000
Q3 2017 Oct 05, 2017	BUY	$39.44 - $41.55 $140,366 - $147,876	3,559	3,559 $145,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Washington Trust Bank, based on Form 13F filings with the SEC.

Stay updated on Washington Trust Bank with notifications on news.